REAL-WORLD, NON-INTERVENTIONAL, OBSERVATIONAL, PATIENT REPORTED OUTCOME STUDY FOR EVALUATING EFFECTIVENESS OF INTENSIVE MOISTURIZING CREAM WITH PLANT BASED BUTTERS (VENUSIA MAX) IN MANAGEMENT OF INDIAN PATIENTS WITH PSORIASIS

Author(s)

Mehta SC1, Jerajani H2, Thomas J3, Netha G4, Shaikh R5, Talathi P6, Gupta A7, Chawla R8, Babu R9, Williams I10, Charugulla SN1, Mittal R1, Acharya S1, Sharma A1
1Dr. Reddy's Laboratories Limited, Hyderabad, India, 2MGM Medical College & Hospital, Mumbai, India, 3JT Skin Care Centre, Chennai, India, 4Gandhi Medical College & Government Hospital, Hyderabad, India, 5Rehmat Clinic & Nursing Home, Thane, India, 6Skin Space Clinic, Mumbai, India, 7Gupta Skin Clinic, New Delhi, India, 8Dr. Ranju Chawla's Skin Clinic, New Delhi, India, 9Raga's Skin Care Clinic, Bengaluru, India, 10Dermicos Skin Clinic, Chennai, India

OBJECTIVES

Real-world, observational study to assess effectiveness, patient reported outcomes(PROs) and safety of intensive moisturizing cream with plant-based butters (Venusia® Max) in Indian patients with psoriasis

METHODS

A 4-week study conducted in 400 psoriatic patients receiving intensive moisturizing cream with plant-based butters (Venusia® Max) in routine clinical practice. PROs in form of Dermatology Life Quality Index (DLQI) questionnaire and Dry Skin/Ichthyosis Area and Severity Index (DASI) score were recorded at week 4 to measure the improvement in quality of life and severity of dryness. Safety and compliance assessment were recorded.

RESULTS :

Mean age of enrolled patients was 43.9 years, 50.8% were males and 49.2% females. Most patients had pre-existing chronic psoriasis, with 49 patients having severe disease at baseline and all were on topical therapy. Reduction in mean DLQI score was 66.7 % at week 4 from baseline (4.2 vs. 10.5, p<0.001) in overall population and 54.4% at week 4 from baseline (7.9 vs. 17.7) for severe psoriatic subgroup. Reduction of mean DASI score was 84.6 % at week 4 from baseline (149.7 vs. 430.5, p<0.001) in overall population and 80.9% at week 4 from baseline (300.4 vs. 734.3) for severe psoriatic subgroup. Similar reduction trend was seen in median DLQI score at week 4 from baseline (2 vs. 9 p<0.001) and median DASI score at week 4 from baseline (100 vs. 420 p<0.001) for overall population. Adverse events, mild to moderate in severity were reported in <3% patients and commonly included itching, fever. More than 90% patients used the cream as instructed by the physician during the study.

CONCLUSIONS :

Use of intensive moisturizing cream with plant-based butters (Venusia® Max) in Indian patients with posriasis was found to be effective, demonstrating a significant reduction in DASI score and significant improvement in quality of life (DLQI) with favorable tolerability profile.

Conference/Value in Health Info

2018-05, ISPOR 2018, Baltimore, MD, USA

Value in Health, Vol. 21, S1 (May 2018)

Code

PSS24

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Sensory System Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×